Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
454 Life Sciences
Genomics company appoints new members to scientific advisory board
September 10th, 2003
454 Life Sciences, an innovative developer of genome-scale sequencing technologies and a majority-owned subsidiary of CuraGen Corporation (CRGN), announced the appointment of the following three individuals to the company's scientific advisory board: 1) Richard Gibbs, PhD, director of the Human Genome Sequencing Center and Wofford Cain professor, Department of Molecular and Human Genetics at Baylor College of Medicine; 2) Jorge Galan, PhD, professor and chairman of Microbial Pathogenesis at the Yale School of Medicine; and 3) W. Ian Lipkin, MD, Jerome L. and Dawn Greene professor of Epidemiology and director, The Jerome L. and...
Source: Biotech Week (2003-09-10)
|
